Spp1−/− and WT mice both developed comparable degrees of hyperglycaemia early after streptozotocin (STZ) treatment (plasma glucose 378 ± 16 mg/dL and 348 ± 20 mg/dL, respectively), indicating comparable efficiency of STZ administration. Here, SPP1 is linked to Hyperglycemia.